Enzo Biochem logo Acadian Asset Management increased its stake in Enzo Biochem, Inc. (NYSE:ENZ) by 1,092.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission.
Lone Star Value Management, LLC ("Lone Star Value") is an investment firm that invests in undervalued securities and engages with its portfolio companies in a constructive way to help maximize value for all shareholders.
Enzo Biochem logo Enzo Biochem, Inc. (NYSE:ENZ) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday, Analyst Ratings.
Enzo Biochem, Inc. logo Zacks Investment Research upgraded shares of Enzo Biochem, Inc. (NYSE:ENZ) from a sell rating to a hold rating in a research report sent to investors on Wednesday, AnalystRatings.
Enzo Biochem logo Enzo Biochem, Inc. (NYSE:ENZ) has been given an average broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports.